Company intelligence / Profile preview
Rottapharm Biotech
Monza, Lombardy, Italyrottapharmbiotech.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Rottapharm Biotech focuses on innovative drug discovery and development in rheumatology, oncology, pain management, infectious diseases, and advanced therapies. Its lead programs include vorbipiprant (an EP4 antagonist) in Phase I/II trials for metastatic gastrointestinal cancers and CR10049 as a first-in-class kinase inhibitor targeting inflammatory osteoarthritis. The company has also developed a DNA vaccine against COVID‑19 with Takis. Historical strengths include the invention of glucosamine sulfate formulations for osteoarthritis.
- Therapeutic areas
- NeurologyInfectious DiseasesOncologyImmunologyRheumatology
- Modalities
- Small moleculeMonoclonal antibodyDNA vaccineProtein
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
Request access →03
Partnerships
Takiscollaborations with academic spin-offs and external biotech companiesSelvita
Beyond the preview
Go deeper on Rottapharm Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rottapharm Biotech.